期刊文献+

性活动与心血管疾病 被引量:3

Sexual Activity and Cardiovascular Diseases
下载PDF
导出
摘要 心血管疾病与性活动关系密切。很多心血管疾病可以影响性功能 ,导致性功能障碍 ,这是长期困扰很多男性的问题。万艾可 (西地那非 )的问世将使这一状况大为改善。现有资料表明万艾可是一种高度安全有效的口服药物 ,心血管副作用很小。若能合理使用 ,可显著改善性功能。另一方面 ,性活动虽为心血管事件的危险因素之一 ,但对心肌梗死影响很小 ,然伴有心绞痛或心力衰竭时仍应注意。分级运动试验有助于评价性活动的安全性。病人遵循一定的康复程序 ,可逐步恢复性功能 。 Cardiovascular diseases have an intimate relationship with sexual activity. Many cardiovascular diseases may cause sexual dysfunction, which has annoyed many men for a long time. The use of sidenafil will greatly better this condition. Data to now demonstrates that sidenafil is a highly effective and safe oral agent, which has little cardiovascular side effects. If correctly used, it will improve sexual function significantly. Sexual activity proved to be one of the risk factors of cardiovascular diseases, however, it has little effect on myocardial infarction. One should be attentive when accompanied by unstable angina or heart failure. Graded exercise tolerance test may be advisable. The patients may follow certain rehabilitation program to restore sexual function, then fulfill truly cardiac rehabilitation.
出处 《中华男科学杂志》 CAS CSCD 2001年第2期113-116,共4页 National Journal of Andrology
关键词 心血管疾病 性活动 勃起功能障碍 万艾可 Cardiovascular diseases Sexual activity Erectile dysfunction Sidenafil
  • 相关文献

参考文献8

  • 1Muller JE. Sexual activity as a trigger for cardiovascular events: what isthe risk?[J] Am J Cardio, 1999, 84(5): 2N~5N.
  • 2Tardif GS. Sexual activity after a myocardial infarction[J]. Arch PhysMed Rehabil, 1989, 70(4): 763~766.
  • 3Tayler HA. Sexual activity and the cardiovascular patients: guidelines[J]. Am J Cardio, 1999, 74(5): 6N~10N.
  • 4Papadopolus C, Shelley SI, Piccolo M et al. Sexual activity after coronarybypass surgery[J]. Chest, 1986, 90(3): 681~685.
  • 5Moss HB, Procci WR. Sexual dysfunction associated with oralantihypertensive medication: a critical survey of the literature[J]. Gen HospPsych, 1982, 4(6): 121~129.
  • 6Nathan HP. A new era in the treatment of erectile dysfunction[J]. Am JCardio, 1999, 84(5): 18N~23N.
  • 7Kloner RA, Zusman RM. Cardiovascular effects of sidenafil citrates andrecommendations for its use[J]. Am J Cardio, 1999, 84(5): 11N~17N.
  • 8ACC/AHA Expert Consensus Document. Use of sidenafil (Viagra)in patientswith cardiovascular disease[J]. Am J Coll Cardio, 1999, 33(1): 273~282.

同被引文献60

  • 1戴若竹,郭炳章,吴德红,曾奕明,杜心清,庄良标.男性急性心肌梗塞后患者恢复性生活情况的调查[J].男性学杂志,1993,7(3):170-171. 被引量:9
  • 2王丽姿,王新,刘辉.冠心病患者性行为的改变和指导[J].中华护理杂志,2007,42(2):183-185. 被引量:11
  • 3Fujisawa M,Sawada K. Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction[J]. Arch Androl, 2004, 50(4):255-260.
  • 4Prieto Castro RM, Anglada Curado FJ, Regueiro Lopez JC, et al. Treatment with sildenafil citrate in renal transplant patients with erectile dysfunction[J]. BJU Int, 2001, 88 (3): 241-243.
  • 5Kassim AA, Fabry ME, Nagel RL. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait [J]. Blood, 2000, 95(5):1878-1879.
  • 6Brindis RG, Kloner RA. Sildenafil in patients with cardiovascular disease[J]. Am J Cardiol, 2003, 92(9A): 26M-36M.
  • 7Mittleman MA, Glasser DB, Orazem J. Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo[J]. Int J Clin Pract, 2003, 57 (7), 597-600.
  • 8Alboni P,Bettiol K,Fuca G, et al. Sexual activity with and without the use of sildenafil: risk of cardiovascular events in patients with heart disease[J]. Ital Heart J, 2004, 5 (5):343-349.
  • 9Shakir SA, Wilton LV, Boshier A, et al. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England [J]. BMJ, 2001, 322(7287): 651-652.
  • 10Manfroi WC, Caramori PR, Zago AJ, et al. Hemodynamic effects of sildenafil in patients with stable ischemic heart disease[J]. Int J Cardiol, 2003, 90(2-3):153-157.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部